The framework of etiology-driven metabolic-immune interactions is proposed by comparing two major etiologies, HBV and MASLD, taking into account the crucial role of lipid metabolism in hepatocarcinogenesis, dietary interventions and lipid metabolism-targeted therapies have also been included so as to offer potential th...
Kai-Tong Mai, Jun-Qing Jiang, Xiang-Long Ma et al.· Biochimica et biophysica act...· 0 citations
This review provides an integrated and conceptual analysis of the HCC immune landscape, delineating the mechanistic drivers underlying immune suppression, summarizes current immune-based classification frameworks, and dissects the context-dependent functions of key immune cell populations in tumor progression.
Jia-Qian Zhang, Si-Wen Li, Xiang-Long Ma et al.· Cancer Biology and Medicine· 0 citations
Hypoxia drives TAM heterogeneity in HCC via an H‑TAM‑intrinsic HIF‑1α-uPA axis that engages uPAR on HCC cells to promote metastasis, and dasatinib is a promising therapy to block this axis and improve outcomes.
Yi-Jun Wang, Xiaomin You, Xiangyuan Luo et al.· Journal of Translational Med...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.